BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17911444)

  • 21. [Lupus erythematosus in pregnancy. A prospective study].
    Chen SL
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):534-7, 573. PubMed ID: 1338515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between outcome of pregnancy and condition of disease at conception in systemic lupus erythematosus women].
    Di W; Pan JX; Hong SY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):414-6, 445-6. PubMed ID: 8001419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Outcome of pregnancies in lupus: experience at one center].
    De Bandt M; Palazzo E; Belmatoug N; M'Bappe P; Hayem G; Kahn MF; Meyer O
    Ann Med Interne (Paris); 2000 Mar; 151(2):87-92. PubMed ID: 10855360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of increased lupus activity on obstetric outcomes.
    Clowse ME; Magder LS; Witter F; Petri M
    Arthritis Rheum; 2005 Feb; 52(2):514-21. PubMed ID: 15692988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of pregnancy in patients with inactive systemic lupus erythromatosus and minimal proteinuria.
    Alshohaib S
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):802-5. PubMed ID: 19736477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
    Qian Q; Liuqin L; Hao L; Shiwen Y; Zhongping Z; Dongying C; Fan L; Hanshi X; Xiuyan Y; Yujin Y
    J Immunol Res; 2015; 2015():316965. PubMed ID: 25973434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors of fetal outcome in systemic lupus erythematosus.
    Rahman P; Gladman DD; Urowitz MB
    J Rheumatol; 1998 Aug; 25(8):1526-30. PubMed ID: 9712095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
    Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic lupus erythematosus and pregnancy (effect of pre-conception hematologic disorders on fetal outcome)].
    Pajor A; Pozsonyi T; Nékám K; Bakos L; Haraszti L; Paulin F
    Orv Hetil; 1998 Feb; 139(8):415-8. PubMed ID: 9524424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic lupus erythematosus. Management during pregnancy.
    Zurier RB; Argyros TG; Urman JD; Warren J; Rothfield NF
    Obstet Gynecol; 1978 Feb; 51(2):178-80. PubMed ID: 304545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus pregnancies: a case series from a tertiary, East Malaysian hospital.
    Teh CL; Wong JS; Ngeh NK; Loh WL
    Lupus; 2009 Mar; 18(3):278-82. PubMed ID: 19213870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone.
    Danowski A; Magder L; Petri M
    J Rheumatol; 2006 Jan; 33(1):57-60. PubMed ID: 16395750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies.
    Mecacci F; Bianchi B; Pieralli A; Mangani B; Moretti A; Cioni R; Giorgi L; Mello G; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Mar; 48(3):246-9. PubMed ID: 19109318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells.
    Blank M; Krause I; Buskila D; Teitelbaum D; Kopolovic J; Afek A; Goldberg I; Shoenfeld Y
    Cell Immunol; 1995 Apr; 162(1):114-22. PubMed ID: 7704899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus.
    Dhar JP; Essenmacher LM; Ager JW; Sokol RJ
    Am J Obstet Gynecol; 2005 Oct; 193(4):1444-55. PubMed ID: 16202739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus.
    Kwok LW; Tam LS; Zhu T; Leung YY; Li E
    Lupus; 2011 Jul; 20(8):829-36. PubMed ID: 21543513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study.
    Saavedra MÁ; Miranda-Hernández D; Sánchez A; Morales S; Cruz-Domínguez P; Medina G; Jara LJ
    Rheumatol Int; 2016 Oct; 36(10):1431-7. PubMed ID: 27387686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bromocriptine for refractory rheumatoid arthritis].
    Mader R
    Harefuah; 1997 Dec; 133(11):527-9, 591. PubMed ID: 9451892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus.
    Mintz G; Rodriguez-Alvarez E
    Rheum Dis Clin North Am; 1989 May; 15(2):255-74. PubMed ID: 2727353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.